IP Library Granted Patent US 8,906,687
Granted Patent B2
US 8,906,687 · App. 11/452,019 · Granted Dec 9, 2014

Blood brain barrier device

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,906,687
App. No.
11/452,019
Granted
Dec 9, 2014
Kind
B2
Abstract

Bone cages are disclosed including devices for biocompatible implantation. The structures of bone are useful for providing living cells and tissues as well as biologically active molecules to subjects.

Claims (40)

1. A device, comprising:

a semi-permeable component including brain endothelial cells having one or more permeability characteristics of a blood brain barrier capillary endothelium;

at least one structural component supporting the semi-permeable component, the at least one structural component at least partially composed of bone, the at least one structural component at least partially defining an internal cavity;

one or more biologically active molecules disposed in the internal cavity of the at least one structural component; and

wherein the semi-permeable component is selectively permeable to the one or more biologically active molecules to allow passage of the one or more biologically active molecules out of the at least one structural component.

2. The device of claim 1 , for implantation in a subject, wherein the bone is autologous, allogeneic or xenogeneic with respect to the subject.

3. The device of claim 2 , wherein the subject is an animal.

4. The device of claim 3 , wherein the animal is selected from the group consisting of a domesticated animal, a farm animal, a marine animal, a sport animal, a wild animal, a research animal, a zoo animal, a bird, an amphibian, a reptile, a fish and a mammal.

5. The device of claim 4 , wherein the mammal is a human.

6. The device of claim 1 , wherein the bone is genetically engineered.

7. The device of claim 1 , wherein the bone binds one or more biologically active molecules.

8. The device of claim 1 , wherein the bone is selected from the group consisting of organic, anorganic, demineralized, freeze-dried, and artificial.

9. The device of claim 1 , wherein the bone is engineered to at least partially prevent restructuring when implanted in a subject.

10. The device of claim 1 , wherein the bone is designed to be at least partially restructured when implanted in a subject.

11. The device of claim 1 , for implantation in a subject, wherein the bone is immunogenic with respect to the subject.

12. The device of claim 1 , for implantation in a subject, wherein the bone is non-immunogenic with respect to the subject.

13. The device of claim 1 , for implantation in a subject, wherein the bone is recognized as self by the subject.

14. The device of claim 1 , wherein the bone is micromachined.

15. The device of claim 1 , wherein the structural component is further at least partially composed of cartilage.

16. The device of claim 15 , for implantation in a subject, wherein the cartilage is autologous, allogeneic or xenogeneic with respect to the subject.

17. The device of claim 16 , wherein the subject is an animal.

18. The device of claim 17 , wherein the animal is selected from the group consisting of a domesticated animal, a farm animal, a marine animal, a sport animal, a wild animal, a research animal, a zoo animal, a bird, an amphibian, a reptile, a fish and a mammal.

19. The device of claim 18 , wherein the mammal is a human.

20. The device of claim 15 , wherein the cartilage is genetically engineered.

21. The device of claim 15 , wherein the cartilage binds one or more biologically active molecules.

22. The device of claim 15 , wherein the cartilage is engineered to at least partially prevent restructuring.

23. The device of claim 15 , wherein the cartilage is designed to be at least partially restructured.

24. The device of claim 15 , wherein the cartilage is at least partially resorbable.

25. The device of claim 15 , for implantation in a subject, wherein the cartilage is immunogenic with respect to the subject.

26. The device of claim 15 , for implantation in a subject, wherein the cartilage is non-immunogenic with respect to the subject.

27. The device of claim 15 , for implantation in a subject, wherein the cartilage is recognized as self by the subject.

28. The device of claim 15 , wherein the cartilage is micromachined.

29. The device of claim 1 , wherein the semi-permeable component at least partially encloses the structural component.

30. The device of claim 1 , wherein the semi-permeable component at least partially surrounded by the structural component.

31. The device of claim 1 , wherein the bone includes living bone cells.

32. A device, comprising:

a semi-permeable component including brain endothelial cells having one or more permeability characteristics of a blood brain barrier capillary endothelium;

a porous bone cage at least partially defining an internal cavity and supporting the semi-permeable component;

one or more biologically active molecules disposed in the internal cavity of the porous bone cage; and

wherein the semi-permeable component is selectively permeable to the one or more biologically active molecules to allow passage of the one or more biologically active molecules out of the porous bone cage.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: THE INVENTION SCIENCE FUND I LLC
To: GEARBOX, LLC
Reel/Frame 037540/0396 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2011
From: SEARETE LLC
To: THE INVENTION SCIENCE FUND I, LLC
Reel/Frame 027319/0012 →